维普期刊资源整合服务平台（V6.5）

136篇 您的检索式：作者名="Brien SG"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Clinical characteristics and outcome in patients with psychogenic nonepileptic seizures 显示文摘	Jones SG O' Brien TJ Adams SJ	2010	Psychosom Med2010，72，5：	1
2	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia显示文摘	Druker BJ Guilhot F O'Brien SG		0，，：	1
3	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia 显示文摘	Druker B J Guilhot F O' Brien SG	2006	N Engl J Med2006，355，23：	1
4	Imatinib compared with interferon and low-dose eytarabine for newly diagnosed chronic-phase chronic myeloid leukemia 显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
5	Managing cutaneous reactions to imatinib therapy 显示文摘	Rule SA O'Brien SG Crossman LC	2002	Blood2002，100，9：	1
6	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia 显示文摘	Dntker B J Guilhot F O' Brien SG	2006	N Engl J Med2006，355，23：	1
7	显示文摘	Druker B J O'Brien SG Cortes J	2002	Soc Sci Med2002，，：	1
8	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O· Brien SG Guilhot F Larson RA	2003	N EnglJMed2003，348，11：	1
9	Imatinib com- pared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia 显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
10	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
11	Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia显示文摘	Hochhaus A O'Brien SG Guilhot F	2009	Leukemia2009，23，6：	1
12	:Imatinib compared withinterferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，99：	1
13	International randomized study of interferon Vs STI571 (iris) 8-year follow up:sustained survival and low risk fur progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase(CML-CP) treated with imatinib显示文摘	DEININGER M O'BRIEN SG FRANCOIS G	2009	Blood (ASH Annu- al Meeting Abstracts)2009，114，：	1
14	:Six-year follow-up ofpatients receiving imatinib for the first-line treatment of chronic mye-loid leukemia显示文摘	Hochhaus A O'Brien SG Guilhot F	2009	Leukemia2009，23，10：	1
15	Five-year fol-low-up of patients receiving imatinib for chronic myeloid leukemia显示文摘	DRUKER BJ GUILHOT F O'BRIEN SG	2006	N Engl J Med2006，355，23：	1
16	Effects of imatinib mesylate(STI571,Glivec)on the pharmacokinetics of simvastatin,a cytochrome P450 3A4 substrate,in patients with chronic myeloid leukaemia显示文摘	O'Brien SG Meinhardt P Bond E	2003	British Journal of Cancer2003，89，10：	1
17	Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid 显示文摘	Takayama N Sato N O' Brien SG	2002	Br J Haematol2002，119，1：	1
18	Oligodeoxynucleotidemediated inhibition of c-myb gene expression in autografted bone marrow:a pilot study显示文摘	Luger SM O' Brien SG Ratajczak J	2002	Blood2002，99，：	1
19	Practical management of patients with chronic myeloid leukemia receiving imatinib显示文摘	Deininger MWN O'Brien SG Ford JM	2003	Journal of Clinical Oncology2003，21，8：	1
20	Clinical results with imatinb in chronic myeloid eukemia显示文摘	Crossman LC O' Brien SG	2004	Leukemia Research2004，28，1：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示